{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:56:55Z","timestamp":1783353415239,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jfma.2021.07.017","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T08:18:26Z","timestamp":1627978706000},"page":"582-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evolution of congenital haemophilia care in Taiwan"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-7723","authenticated-orcid":false,"given":"Yeu-Chin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yau","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-4393","authenticated-orcid":false,"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7683-6010","authenticated-orcid":false,"given":"Tsung-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.07.017_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3349\/ymj.2013.54.1.71","article-title":"Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan","volume":"54","author":"Tu","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jfma.2021.07.017_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/08989621.2014.882780","article-title":"Blood money: Bayer's inventory of HIV-contaminated blood products and third world hemophiliacs","volume":"21","author":"McHenry","year":"2014","journal-title":"Account Res"},{"issue":"Suppl. 3","key":"10.1016\/j.jfma.2021.07.017_bib3","first-page":"30","article-title":"Comorbidities and HIV infection of hemophiliacs in Taiwan: a population-based study","volume":"20","author":"Cheng","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib4","series-title":"National health insurance statistics for catastrophic illness patients","author":"Taiwan National Health Insurance Administration of the Ministry of Health and Welfare","year":"2020"},{"key":"10.1016\/j.jfma.2021.07.017_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/hae.12373","article-title":"Trends in the epidemiology, diagnosed age and mortality rate of haemophiliacs in Taiwan: a population-based study, 1997-2009","volume":"20","author":"Chang","year":"2014","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.jfma.2021.07.017_bib6","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.jval.2018.07.726","article-title":"Disease burden and utilisation patterns of coagulation factors for patients with hemophilia in Taiwan","volume":"21","author":"Lai","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jfma.2021.07.017_bib7","series-title":"National health insurance statistics for catastrophic illness patients","author":"Taiwan National Health Insurance Administration of the Ministry of Health and Welfare","year":"2020"},{"issue":"8","key":"10.1016\/j.jfma.2021.07.017_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Data and demographics committee of the world federation of hemophilia. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2021.07.017_bib9","first-page":"1","article-title":"Transfusion-transmitted infection and comorbidities in patients with severe haemophilia: a longitudinal birth cohort analysis","author":"Wang","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2516.2008.01687.x","article-title":"The spectrum of the factor 8 (F8) defects in Taiwanese patients with haemophilia A","volume":"14","author":"Ma","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2350-9-53","article-title":"Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical applications of HRM","volume":"9","author":"Lin","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jfma.2021.07.017_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2516.2009.02180.x","article-title":"Genetic analysis of haemophilia A in Taiwan","volume":"16","author":"Chen","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2516.2005.01069.x","article-title":"Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype","volume":"11","author":"Hill","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2516.2005.01121.x","article-title":"Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modeling of 10 novel missense substitutions","volume":"11","author":"Jayandharan","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0037-1613212","article-title":"11 haemophilia A patients without mutations in the factor VIII encoding gene","volume":"88","author":"Klopp","year":"2002","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jfma.2021.07.017_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1538-7836.2005.01140.x","article-title":"Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene","volume":"3","author":"El-Maarri","year":"2005","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jfma.2021.07.017_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ejh.13242","article-title":"Deep intronic variant c.5999-277G>A of F8 gene may be a hot spot mutation for mild hemophilia A patients without mutation in exonic DNA","volume":"103","author":"Chang","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jfma.2021.07.017_bib18","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1538-7836.2011.04408.x","article-title":"Deep intronic variants may cause mild hemophilia A","volume":"9","author":"Castaman","year":"2011","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jfma.2021.07.017_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/jth.12339","article-title":"Deep intronic \u2018mutations\u2019 cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA","volume":"11","author":"Pezeshkpoor","year":"2013","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jfma.2021.07.017_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.kjms.2013.12.003","article-title":"Efficient detection of fact or IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations","volume":"30","author":"Lin","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jfma.2021.07.017_bib21","series-title":"Executive report regarding treatment fees designated for rare diseases and hemophilia","author":"Taiwan National Health Insurance Administration of the Ministry of Health and Welfare","year":"2014"},{"key":"10.1016\/j.jfma.2021.07.017_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.07.017_bib23","series-title":"World federation of hemophilia report on the annual global survey","year":"2019"},{"key":"10.1016\/j.jfma.2021.07.017_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178883","article-title":"Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients","volume":"12","author":"Jang","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.07.017_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jfma.2013.10.010","article-title":"Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan","volume":"113","author":"Lin","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2021.07.017_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/17474086.2018.1486704","article-title":"Prophylactic versus on-demand treatments for hemophilia: advantages and drawbacks","volume":"11","author":"Castaman","year":"2018","journal-title":"Expet Rev Hematol"},{"key":"10.1016\/j.jfma.2021.07.017_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/17474086.2018.1489719","article-title":"The benefits of prophylaxis in patients with hemophilia B","volume":"11","author":"Castaman","year":"2018","journal-title":"Expet Rev Hematol"},{"key":"10.1016\/j.jfma.2021.07.017_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2516.2010.02367.x","article-title":"Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan","volume":"17","author":"Liou","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib29","series-title":"Analysis of the reasonableness of increases to the designated budgets for rare disease, hemophilia, and HIV treatment","author":"Taiwan National Health Insurance Administration of the Ministry of Health and Welfare","year":"2019"},{"key":"10.1016\/j.jfma.2021.07.017_bib30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/pbc.23291","article-title":"Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens","volume":"57","author":"Lin","year":"2011","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.jfma.2021.07.017_bib31","series-title":"Abstract 03-03. Presented at the 7th East Asia Hemophilia forum in Taichung, Taiwan; October 6-8","article-title":"Baseline data of hemophilia patients in Taiwan: a multicenter survey study","author":"Lin","year":"2017"},{"key":"10.1016\/j.jfma.2021.07.017_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jcma.2017.11.016","article-title":"Outcome of perioperative hemostatic management in patients with hemophilia without inhibitors undergoing 161 invasive or surgical procedures","volume":"81","author":"Tong","year":"2018","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2021.07.017_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/hae.12074","article-title":"Treatment guidelines working group on behalf of the world federation of hemophilia. Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib34","article-title":"The utilisation of rehabilitation in patients with hemophilia A in Taiwan: a nationwide population-based study","volume":"11","author":"Chen","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2021.07.017_bib35","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1111\/hae.12644","article-title":"The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study","volume":"21","author":"Chen","year":"2015","journal-title":"Haemophilia"},{"issue":"S5","key":"10.1016\/j.jfma.2021.07.017_bib36","first-page":"566","article-title":"Weekend group rehabilitation course increasing range of motion in patients with hemophilic arthropathy of the knee","volume":"24","author":"Li","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/health.2013.510A1001","article-title":"Investigated the hospital utilisation and medical resource usage of haemophilia A and B in Taiwan: 2001-2010","volume":"5","author":"Yan","year":"2013","journal-title":"Health"},{"key":"10.1016\/j.jfma.2021.07.017_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3349\/ymj.2013.54.2.358","article-title":"Economic burden of high-responding inhibitors in patients with hemophilia A in Taiwan","volume":"54","author":"Tu","year":"2013","journal-title":"Yonsei Med J"},{"issue":"5 Suppl","key":"10.1016\/j.jfma.2021.07.017_bib39","first-page":"s126","article-title":"Economic costs of hemophilia and the impact of prophylactic treatment on patient management","volume":"22","author":"Chen","year":"2016","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jfma.2021.07.017_bib40","first-page":"632","article-title":"Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia","volume":"24","author":"Thorat","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jfma.2021.07.017_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13023-017-0660-y","article-title":"The cost of severe haemophilia in Europe: the CHESS study","volume":"12","author":"O'Hara","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.jfma.2021.07.017_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009803","article-title":"Risk of major comorbidities among workers with hemophilia: a 14-year population-based study","volume":"97","author":"Chu","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jfma.2021.07.017_bib43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/hae.13117","article-title":"Prevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophilia","volume":"23","author":"Chang","year":"2017","journal-title":"Haemophilia"},{"issue":"S5","key":"10.1016\/j.jfma.2021.07.017_bib44","first-page":"72","article-title":"Joint outcomes of the elbow, knee and ankles evaluated by hemophilia joint health score in patients with hemophilia: trends by age and clinical predictors","volume":"24","author":"Chang","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib45","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2106\/JBJS.K.01646","article-title":"Hemophilic arthropathy of shoulder joints: clinical, radiographic, and ultrasonographic characteristics of seventy patients","volume":"95","author":"Chen","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jfma.2021.07.017_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/JCMA.0000000000000047","article-title":"Obesity and overweight in patients with haemophilia: prevalence by age, clinical correlates, and impact on joint bleeding","volume":"82","author":"Chang","year":"2019","journal-title":"J Chin Med Assoc"},{"issue":"46","key":"10.1016\/j.jfma.2021.07.017_bib47","doi-asserted-by":"crossref","first-page":"e5384","DOI":"10.1097\/MD.0000000000005384","article-title":"Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"S5","key":"10.1016\/j.jfma.2021.07.017_bib48","first-page":"574","article-title":"18F-FDG PET\/CT imaging of hemophilic arthropathy correlates with power Doppler ultrasonography","volume":"24","author":"Li","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fjs.2015.09.003","article-title":"Arthroscopic synovectomy considerably reduces bleeding frequency and improves joint function in hemophilic patients with chronic synovitis","volume":"49","author":"Wu","year":"2016","journal-title":"Formos J Surg"},{"key":"10.1016\/j.jfma.2021.07.017_bib50","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/hae.13711","article-title":"An exploratory comparison of single intra-articular injection of platelet-rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee","volume":"25","author":"Li","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/jmedsci.jmedsci_33_18","article-title":"Efficacy, safety, and synovial effects of intra-articular hyaluronic acid in treating recalcitrant hemophilic arthropathy of knee joint","volume":"39","author":"Li","year":"2019","journal-title":"J Med Sci"},{"key":"10.1016\/j.jfma.2021.07.017_bib52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2516.2008.01693.x","article-title":"Total knee arthropathy for severe haemophilic arthropathy: long-term experience in Taiwan","volume":"14","author":"Chiang","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618794294","article-title":"Comparison of total joint replacement rate between patients with haemophilia A and patients with haemophilia B: a population-based and retrospective cohort study","author":"Lin","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jfma.2021.07.017_bib54","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.arth.2019.05.062","article-title":"Does hemophilia increase risk of adverse outcomes following total hip and knee arthroplasty? A propensity score-matched analysis of a nationwide, population-based study","volume":"34","author":"Wang","year":"2019","journal-title":"J Arthroplasty"},{"issue":"4","key":"10.1016\/j.jfma.2021.07.017_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/hae.12339","article-title":"Cardiovascular comorbidities are increased in US patients with haemophilia A: a retrospective database analysis","volume":"20","author":"Pocoski","year":"2014","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.jfma.2021.07.017_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jch.13747","article-title":"Asian management of hypertension: current status, home blood pressure, and specific concerns in Taiwan","volume":"22","author":"Cheng","year":"2020","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jfma.2021.07.017_bib57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.thromres.2014.12.027","article-title":"Prevalence and risk factors of atherothrombotic events among 1054 haemophilia patients: a population-based analysis","volume":"135","author":"Wang","year":"2015","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2021.07.017_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12959-016-0097-x","article-title":"Comorbidities of cardiovascular disease and cancer in hemophilia patients","volume":"14","author":"Wang","year":"2016","journal-title":"Thromb J"},{"key":"10.1016\/j.jfma.2021.07.017_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1160\/TH12-05-0332","article-title":"Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients","volume":"109","author":"Fransen van de Putte","year":"2013","journal-title":"Thromb Haemostasis"},{"issue":"S5","key":"10.1016\/j.jfma.2021.07.017_bib60","first-page":"91","article-title":"Prevalence of depression and anxiety disorders in patients with hemophilia: a nationwide cohort study","volume":"24","author":"Huang","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jfma.2021.07.017_bib61","series-title":"2018 usage statistics for NHI reimbursed drugs","author":"Taiwan National Health Insurance Administration of the Ministry of Health and Welfare","year":"2019"},{"key":"10.1016\/j.jfma.2021.07.017_bib62","series-title":"2018 annual global survey","year":"2019"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462100348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462100348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:46:20Z","timestamp":1760539580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462100348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S092966462100348X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.07.017","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of congenital haemophilia care in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}